# Isosorbide 5-Mononitrate

## Coxine 20mg

##### 

| TAH Drug Code      | OCOX                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prophylaxis of angina pectoris.                                                                                                                                                                                           |
| Dosing             | Initial dose: 5-10 mg (1/4-1/2 tablets) BID separate 7 hours apart for day 1 and day 2, then increase to 20 mg BID for 2 days. Maintain dose: 20 mg BID.                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                             |
| Contraindications  | Marked hypotension, hypertrophic obstructive cardiomyopathy, constrictive pericarditis, aortic & mitral stenosis, increased intracranial pressure, MI with low filling pressure. Avoid sildenafil, tadalafil, vardenafil. |
| Adverse Effects    | Transient headache, nausea, dizziness, weakness, vomiting, tachycardia, decreased BP, possible formation of methemoglobin, rarely allergic skin reactions. Neurologic: Dizziness (8% to 11% ), Headache (38% to 57% )     |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                             |

## Ibimo C.R.F.C. 60 mg

##### 

| TAH Drug Code      | OIBI                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of angina pectoris.                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | 60 mg in the morning, may be increased to 120 mg once daily. Reduce to 0.5 tab when headache occurs.                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Allergic to isosorbide mononitrate, isosorbide dinitrate, other nitrates or nitrites. Low blood pressure (<90mmHg), circulatorycollapse, Shock, or with failing heart, unless could keep blood pressure. Angina caused by hypertrophic cardiomyopathy may be aggravated. Increased intracranial pressure. Pericarditis.                                                                             |
| Adverse Effects    | Common Dizziness (Extended-release, 8% to 11%), Headache (Extended-release, 38% to 57%), Orthostatic Hypotension Serious Cardiovascular: Atrial fibrillation (5% or less), Bradyarrhythmia (5% or less ), Bundle branch block (5% or less), Chest pain (Immediate-release, up to 2% ), Heart failure (5% or less ), Hemorrhage, Ventricular tachycardia (5% or less), Angina pectoris (5% or less), |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                       |

